Category: Generative AI & LLMs
Decades of protocols, reports, correspondence, and site documents sit in PDFs and file shares that can't be searched by meaning — so teams re-create knowledge the organization already owns.
Pharma organizations accumulate enormous written archives — protocols, study reports, regulatory correspondence, quality records, site documents — but almost all of it lives as unstructured text in PDFs and document systems that only support filename and keyword search. The result is familiar: teams redo analyses, re-draft language, and re-learn lessons that already exist somewhere in the archive, because finding the precedent costs more than starting over. Document-intelligence and language-model tools convert that archive into something that can be queried, extracted from, and reused.
Two capabilities do most of the work. Extraction turns documents into structured data: reading a protocol and pulling its design attributes, reading correspondence and indexing the questions asked, reading quality records and categorizing what happened — at a scale no manual effort could attempt. Semantic search finds documents by meaning rather than keyword, so a question phrased in one team's vocabulary reaches a precedent written in another's. The honest limitation is that extraction quality varies with document quality and layout, and no extraction at this scale is perfect. Well-designed deployments carry confidence signals and page-level links back to the source document, so users treat extracted answers as leads to verify rather than facts to cite — and the decisions built on those answers still rest with the people making them.
Test extraction on your real documents — including the old, scanned, and inconsistently formatted ones that dominate real archives, not the clean examples a demo favors. Measure accuracy on a sample your team verifies by hand, and check whether the tool exposes confidence and source-page links so downstream users can tell solid extractions from uncertain ones. Ask how the system behaves on document types it has not seen before, and what the correction workflow looks like when users find errors. Security and access control deserve equal weight: an archive-wide index inherits the sensitivity of everything in it, so document-level permissions must survive into search results — a query should never surface content its asker could not have opened directly.
Successful adoptions usually pick one high-value corpus and one recurring question rather than indexing everything at once — protocol archives queried for design precedents, or regulatory correspondence queried for prior agency positions, are common first targets. The pilot measures extraction accuracy against hand-verified samples and, more tellingly, whether the team actually finds precedents faster on real work. Expanding corpus by corpus keeps quality measurable and lets access-control questions get settled at manageable scale.
Modern document-intelligence systems handle the mix a real archive contains — digital PDFs, scanned pages, tables, and forms — but accuracy varies with quality and layout, and older scanned material is measurably harder. That is why evaluation should use your actual archive rather than clean samples, and why source-page links matter for verification.
It depends on your documents, and any tool should be tested against a hand-verified sample from your own archive before the numbers are trusted. Well-designed systems expose confidence signals and link every extraction to its source page, so users can verify uncertain answers instead of consuming them blindly.
It can if permissions are ignored: indexing an archive makes everything in it findable. Insist that document-level access control carries through to search and extraction results, so a query returns only content the asker could have opened directly. This should be tested explicitly during evaluation, not assumed.
Recurring precedent questions — what designs we used before, what an agency said last time, how a prior document handled a situation — because the answer demonstrably exists in the archive and the cost of finding it by hand is what the tool removes. One corpus and one question class make a measurable pilot.
Syntegra partnered with Datavant to connect its synthetic data engine with Datavant's de-identification and record-linking network, enabling privacy-preserving exchange of synthetic versions of linked real-world health datasets across the healthcare ecosystem.
Vendor: Syntegra · press release (Syntegra (GlobeNewswire)) · 2022-12-15 — Partner: Datavant
Abridge was named the first member of Epic's 'Pals' partnership program, integrating its generative-AI medical conversation summaries directly into Epic EHR workflows so health systems can adopt ambient documentation inside the tools clinicians already use.
Vendor: Abridge · press release (Abridge) · 2023-08-16 — Partner: Epic
Saama's AI-driven clinical analytics supported Pfizer's review of clinical trial data during its COVID-19 vaccine program; the companies subsequently expanded their relationship across Pfizer's broader R&D data operations.
Vendor: Saama Technologies · press release (Saama (Business Wire)) · 2024-02-12 — Partner: Pfizer
Kaiser Permanente rolled out Abridge's ambient AI clinical documentation technology across its integrated health system — 40 hospitals and more than 600 medical offices — letting clinicians generate draft visit notes from patient conversations instead of typing during encounters.
Vendor: Abridge · press release (Kaiser Permanente) · 2024-08-14 — Partner: Kaiser Permanente
A quality-improvement survey at the University of Kansas Medical Center, published in JAMIA Open, reported that clinicians using Abridge's ambient AI documentation self-reported lower perceived work burden and burnout and higher job satisfaction after implementation. Vendor-affiliated authors participated in the study.
Vendor: Abridge · peer reviewed (JAMIA Open (Oxford University Press)) · 2025-02-21